Metabolic therapeutics therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Type 2 Diabetes (Metabolic Disorder) - Drugs in Development, 2021By Global Markets Direct "...... eline landscape.Type 2 diabetes is a chronic condition and is the most common form of diabetes. High levels of glucose are a characteristic feature. The body might become resistant to insulin or may not produce enough amounts. Due to abnormal insulin......" | 31-Oct-2021 | $2500 | |
Hypercholesterolemia (Metabolic Disorder) - Drugs in Development, 2021By Global Markets Direct "...... Disorders) pipeline landscape.Hypercholesterolemia is a condition characterized by very high levels of cholesterol in the blood. This leads in formation of sticky deposits (called plaque) along the artery walls. Plaque can completely block blood flo......" | 31-Oct-2021 | $2000 | |
Heterozygous familial hypercholesterolemia (heFH) (Metabolic Disorder) - Drugs in Development, 2021By Global Markets Direct "...... an overview of the Heterozygous familial hypercholesterolemia (Metabolic Disorders) pipeline landscape.Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder caused due to a mutation (alteration) of FH from one (affected) parent. Sy......" | 31-Oct-2021 | $2000 | |
Obesity (Metabolic Disorder) - Drugs in Development, 2021By Global Markets Direct "...... is defined as having an excessive amount of body fat. Obesity increases risk of diseases and health problems such as heart disease, diabetes and high blood pressure. The predisposing factors include age, family history, quitting smoking, lack of slee......" | 31-Oct-2021 | $2500 | |
Inclusion Body Myositis (IBM) (Metabolic Disorder) - Drugs In Development, 2021By Global Markets Direct "...... itis (Musculoskeletal Disorders) pipeline landscape.Inclusion Body Myositis (IBM) is one of the inflammatory myopathies that involve inflammation of the muscles or associated tissues, such as the blood vessels that supply the muscles. IBM symptoms in......" | 30-Aug-2021 | $2000 | |
Methylmalonic Acidemia (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... information on the therapeutics under development for Methylmalonic Acidemia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descrip......" | 30-Apr-2021 | $2000 | |
Cardiometabolic Disease (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... ive information on the therapeutics under development for Cardiometabolic Disease, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the des......" | 30-Apr-2021 | $2000 | |
Homozygous Familial Hypercholesterolemia (HoFH) (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... a (HoFH) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Homozygous Familial Hypercholesterolemia (HoFH), complete with analysis by Stage of Development, Drug Target, Mechanism ......" | 30-Apr-2021 | $2000 | |
Cushing's Syndrome (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... on the therapeutics under development for Cushing's Syndrome, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacolog......" | 30-Apr-2021 | $2000 | |
Diabetic Complications (Metabolic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... information on the therapeutics under development for Diabetic Complications, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descrip......" | 30-Apr-2021 | $2000 | |
|